What does DR. BONTE CARIN do?

DR. BONTE CARIN is a specialist medical practice in Brugge. Private Limited, started on 2 March 2005, 1 establishment.

What is the address of DR. BONTE CARIN?

The registered office of DR. BONTE CARIN is located at Brieversweg 115, 8310 Brugge.

Is DR. BONTE CARIN still active?

Yes. According to the CBE (3 October 2026) DR. BONTE CARIN is active, legal situation “Normale toestand”, started on 2 March 2005.

Is DR. BONTE CARIN registered on Peppol?

Yes, DR. BONTE CARIN is registered on the Peppol network with ID 0208:0872217862.

What is the enterprise number of DR. BONTE CARIN?

The enterprise number of DR. BONTE CARIN is BE0872217862.

When was DR. BONTE CARIN founded?

DR. BONTE CARIN was founded on 2 March 2005.

Who are the directors of DR. BONTE CARIN?

According to the 2025 annual accounts, the directors of DR. BONTE CARIN are: Carin Bonte.

Is DR. BONTE CARIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 March 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. BONTE CARIN make in 2025?

DR. BONTE CARIN posted a profit after taxes of € 174,235 in financial year 2025.

What is the revenue of DR. BONTE CARIN?

As a small company, DR. BONTE CARIN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 300,281.

DR. BONTE CARIN (Private Limited) - Brugge - BE0872217862

Dossier DR. BONTE CARIN, printed on 3 October 2026 from databakkes.be/en/0872217862/dr-bonte-carin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. BONTE CARIN from Brugge, company number BE0872217862, closed financial year 2025 with a result of € 174,235 after tax. For that financial year DR. BONTE CARIN recorded a gross margin of € 300,281 and equity of € 1 million. Compared with financial year 2024, the result moved from € 174,740 to € 174,235. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Growing

€ 1 million

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 174,235

Profit after tax over the fiscal year.

Cash in the bank

€ 158,681

▲ 60% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

57 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 297,313

▼ 8% vs 2024

Of which on lease € 294,145.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 287,317

▼ 12% vs 2024

€ 58,713 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 3,020

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 21,341

▼ 6% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 302,428 Gross margin 2022: € 302,428 First fiscal year in the series	€ 322,705 Gross margin 2023: € 322,705 ▲ 7% vs 2022 (€ 302,428) Favourable step	€ 303,939 Gross margin 2024: € 303,939 ▼ 6% vs 2023 (€ 322,705) Unfavourable step	€ 300,281 Gross margin 2025: € 300,281 ▼ 1% vs 2024 (€ 303,939) Unfavourable step	▼ 1%
Profit after taxes	€ 164,606 Profit after taxes 2022: € 164,606 First fiscal year in the series	€ 181,040 Profit after taxes 2023: € 181,040 ▲ 10% vs 2022 (€ 164,606) Favourable step	€ 174,740 Profit after taxes 2024: € 174,740 ▼ 3% vs 2023 (€ 181,040) Unfavourable step	€ 174,235 Profit after taxes 2025: € 174,235 Unchanged (€ 174,740) Unfavourable step
Equity	€ 785,108 Equity 2022: € 785,108 First fiscal year in the series	€ 932,148 Equity 2023: € 932,148 ▲ 19% vs 2022 (€ 785,108) Favourable step	€ 968,888 Equity 2024: € 968,888 ▲ 4% vs 2023 (€ 932,148) Favourable step	€ 1,043,123 Equity 2025: € 1,043,123 ▲ 8% vs 2024 (€ 968,888) Favourable step	▲ 8%
Total debts	€ 443,715 Total debts 2022: € 443,715 First fiscal year in the series	€ 451,897 Total debts 2023: € 451,897 ▲ 2% vs 2022 (€ 443,715) Unfavourable step	€ 426,525 Total debts 2024: € 426,525 ▼ 6% vs 2023 (€ 451,897) Favourable step	€ 411,678 Total debts 2025: € 411,678 ▼ 3% vs 2024 (€ 426,525) Favourable step	▼ 3%
Cash	€ 200,474 Cash 2022: € 200,474 First fiscal year in the series	€ 177,250 Cash 2023: € 177,250 ▼ 12% vs 2022 (€ 200,474) Unfavourable step	€ 99,187 Cash 2024: € 99,187 ▼ 44% vs 2023 (€ 177,250) Unfavourable step	€ 158,681 Cash 2025: € 158,681 ▲ 60% vs 2024 (€ 99,187) Favourable step	▲ 60%
Land & buildings	€ 435,579 Land & buildings 2022: € 435,579 First fiscal year in the series	€ 422,879 Land & buildings 2023: € 422,879 ▼ 3% vs 2022 (€ 435,579) Unchanged	€ 410,180 Land & buildings 2024: € 410,180 ▼ 3% vs 2023 (€ 422,879) Unchanged	€ 407,480 Land & buildings 2025: € 407,480 ▼ 1% vs 2024 (€ 410,180) Unchanged	▼ 1%
Retained profit	€ 766,508 Retained profit 2022: € 766,508 First fiscal year in the series	€ 913,548 Retained profit 2023: € 913,548 ▲ 19% vs 2022 (€ 766,508) Favourable step	€ 950,288 Retained profit 2024: € 950,288 ▲ 4% vs 2023 (€ 913,548) Favourable step	€ 1,024,523 Retained profit 2025: € 1,024,523 ▲ 8% vs 2024 (€ 950,288) Favourable step	▲ 8%
Dividend	€ 120,000 Dividend 2022: € 120,000 First fiscal year in the series	€ 34,000 Dividend 2023: € 34,000 ▼ 72% vs 2022 (€ 120,000) Unchanged	€ 138,000 Dividend 2024: € 138,000 ▲ € 104,000 vs 2023 (€ 34,000) Unchanged	€ 100,000 Dividend 2025: € 100,000 ▼ 28% vs 2024 (€ 138,000) Unchanged	▼ 28%
Bank debt	€ 409,278 Bank debt 2022: € 409,278 First fiscal year in the series	€ 368,900 Bank debt 2023: € 368,900 ▼ 10% vs 2022 (€ 409,278) Favourable step	€ 325,748 Bank debt 2024: € 325,748 ▼ 12% vs 2023 (€ 368,900) Favourable step	€ 287,317 Bank debt 2025: € 287,317 ▼ 12% vs 2024 (€ 325,748) Favourable step	▼ 12%
Balance sheet total	€ 1,241,289 Balance sheet total 2022: € 1,241,289 First fiscal year in the series	€ 1,395,661 Balance sheet total 2023: € 1,395,661 ▲ 12% vs 2022 (€ 1,241,289) Unchanged	€ 1,406,178 Balance sheet total 2024: € 1,406,178 ▲ 1% vs 2023 (€ 1,395,661) Unchanged	€ 1,464,714 Balance sheet total 2025: € 1,464,714 ▲ 4% vs 2024 (€ 1,406,178) Unchanged	▲ 4%

Key figures of DR. BONTE CARIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. BONTE CARIN?

What happened at DR. BONTE CARIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 8, 2026 New annual accounts for financial year 2025: profit of € 174,235. Source: NBB ↗
Jan 1, 2008 New establishment in Brugge. KBO
Mar 2, 2005 Start of the company according to the CBE. KBO
2005 Carin Bonte became a director. NBB

In short

From € 164,606 profit in 2022 to € 174,235 profit in 2025.

Paid € 309,596 in corporate taxes since 2022.

Best year ever: 2023, with € 181,040 profit.

Paid out € 392,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. BONTE CARIN? We notify you, reason included.

Follow DR. BONTE CARIN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Carin Bonte

DR. BONTE CARIN

Behind DR. BONTE CARIN is Carin Bonte.

See the full network in the app

Directors

According to the 2025 annual accounts

Carin Bonte

Director

since 2005

Establishments

Establishment units

Physical locations of this company

Registered office

Brieversweg 115

8310 Brugge

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0872.217.862
VAT number: BE 0872.217.862
Registered office: Brieversweg 115, 8310 Brugge
Names & denominations: DR. BONTE CARIN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 March 2005
Peppol: Active · Active since 5 Oct 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗